Dynavax Technologies Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio61.474.6323.39
Forward P/E42.2253.268.61
P/S Ratio6.057.781.883.8412.18
P/B Ratio2.812.902.347.598.35
Price/Tangible Book2.822.922.357.668.69
Price/FCF27.9018.7324.435.18
Price/OCF25.2417.9721.645.03
Enterprise Value Ratios
EV/Revenue4.225.791.423.4813.21
EV/EBITDA211.863.5010.53
EV/EBIT1310.853.5410.85
EV/FCF19.4413.9418.514.70
Profitability & Returns
Return on Equity (ROE)0.04%-0.01%0.73%0.55%-2.25%
Return on Assets (ROA)0.00%-0.02%0.18%0.13%-0.15%
Return on Invested Capital (ROIC)0.01%-0.17%3.90%6.17%-0.78%
Return on Capital Employed (ROCE)0.00%-0.03%0.35%0.29%-0.27%
Leverage & Solvency Ratios
Debt/Equity0.430.410.441.163.71
Debt/EBITDA21.260.861.70
Debt/FCF4.232.664.640.79
Liquidity Ratios
Current Ratio10.8013.816.111.753.75
Quick Ratio9.6812.675.621.332.42
Efficiency Ratios
Asset Turnover0.280.230.710.630.13
Inventory Turnover1.751.825.113.290.76
Yield & Distribution Ratios
Earnings Yield0.02%0.00%0.22%0.05%-0.15%
FCF Yield0.04%0.05%0.04%0.19%-0.20%
Buyback Yield-0.04%0.15%-0.13%-0.31%-0.41%